• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

National Standard (India) Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
504882
INE166R01015
141
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATIONSTD
246.28
2379.1
EPS(TTM)
Face Value()
Div & Yield %
4.83
10
0
 

maruti suzuki india ltd
Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter
May 14,2026
Net profit of Beta Drugs rose 0.22% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 9.03 crore during the previous quarter ended March 2025. Sales rose 0.21% to Rs 93.96 crore in the quarter ended March 2026 as against Rs 93.76 crore during the previous quarter ended March 2025.

For the full year,net profit declined 2.22% to Rs 41.48 crore in the year ended March 2026 as against Rs 42.42 crore during the previous year ended March 2025. Sales rose 6.20% to Rs 384.83 crore in the year ended March 2026 as against Rs 362.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales93.9693.76 0 384.83362.36 6
OPM %18.8218.50 -19.6720.59 -
PBDT16.6318.02 -8 71.5574.05 -3
PBT11.8314.45 -18 54.3961.54 -12
NP9.059.03 0 41.4842.42 -2